The comparative clinical pharmacology of vincristine and vindesine: Does vindesine offer any advantage in clinical use?

被引：22

作者：

Joel, S

机构：

[1] Medical Oncology Department, St Bartholomew's Hospital, London

来源：

CANCER TREATMENT REVIEWS | 1995年 / 21卷 / 06期

关键词：

D O I：

10.1016/0305-7372(95)90015-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：513 / 525

页数：13

共 76 条

[61] IS THERE A ROLE FOR VINDESINE IN THE TREATMENT OF NONSMALL CELL LUNG-CANCER [J].

SORENSEN, JB ;

HANSEN, HH .

INVESTIGATIONAL NEW DRUGS, 1993, 11 (2-3) :103-133

[62]

SORENSEN JB, 1988, CANCER CHEMOTH PHARM, V21, P103

[63]

SORENSEN JB, 1988, CANCER CHEMOTH PHARM, V21, P89

[64] VINCA ALKALOIDS IN THE TREATMENT OF NON-SMALL CELL LUNG-CANCER [J].

SORENSEN, JB ;

OSTERLIND, K ;

HANSEN, HH .

CANCER TREATMENT REVIEWS, 1987, 14 (01) :29-51

[65]

SORENSEN JB, 1992, DRUGS, V4, P60

[66]

Stryckmans P, 1991, Baillieres Clin Haematol, V4, P115, DOI 10.1016/S0950-3536(05)80287-2

[67]

TAKAGI T, 1993, INT J HEMATOL, V57, P67

[68] TOXICOLOGY OF VINDESINE (DESACETYL VINBLASTINE AMIDE) IN MICE, RATS, AND DOGS [J].

TODD, GC ;

GIBSON, WR ;

MORTON, DM .

JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1976, 1 (05) :843-849

[69] SEQUENTIAL CHEMOTHERAPY IN GOOD-PROGNOSIS PATIENTS WITH SMALL-CELL LUNG-CANCER [J].

TWELVES, CJ ;

GOLDMAN, J ;

ASH, CM ;

SOUHAMI, RL ;

HARPER, PG ;

SPIRO, SG ;

GEDDES, D ;

TOBIAS, JS .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 28 (02) :139-141

[70] A STUDY OF TOXICITY AND COMPARATIVE THERAPEUTIC EFFICACY OF VINDESINE-PREDNISONE VS VINCRISTINE-PREDNISONE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA IN RELAPSE - A PEDIATRIC ONCOLOGY GROUP-STUDY [J].

VATS, T ;

BUCHANAN, G ;

MEHTA, P ;

RAGAB, A ;

HVIZDALE, E ;

NITSCHKE, R ;

LINK, M ;

BEARDSLEY, GP ;

MAYBEE, D ;

KRISCHER, J .

INVESTIGATIONAL NEW DRUGS, 1992, 10 (03) :231-234

← 1 2 3 4 5 6 7 8 →